MA-GVHD-401 MA-GVHD-401: A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

NCT05919511

MA-GVHD-401: A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Principal Investigator

Sponsor

Incyte Corporation

Describe the clinical course and burden of cGVHD after alloSCT. Describe personal and healthcare resource utilization associated with the management of
cGVHD. Describe practice patterns and therapy strategies in participants treated for cGVHD in both community and academic settings, including frequency, safety, and effectiveness of steroids. Assess the impact of SCT and cGVHD on organ specific symptoms as reported by participants. Assess the predictive, diagnostic, and prognostic associations of blood cytology with
cGVHD.

This study is currently enrolling.